Leishmania major LmACR2 Is a Pentavalent Antimony Reductase That Confers Sensitivity to the Drug Pentostam
Open Access
- 1 September 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (36) , 37445-37451
- https://doi.org/10.1074/jbc.m404383200
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- As(III) and Sb(III) Uptake by GlpF and Efflux by ArsB in Escherichia coliJournal of Biological Chemistry, 2004
- Arsenic trioxide uptake by human and rat aquaglyceroporinsBiochemical and Biophysical Research Communications, 2004
- Soldiers battle 'Baghdad boil'Nature Medicine, 2004
- Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9Proceedings of the National Academy of Sciences, 2002
- Novel Intracellular SbV Reducing Activity Correlates with Antimony Susceptibility in Leishmania donovaniJournal of Biological Chemistry, 2001
- Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian EpidemicClinical Infectious Diseases, 2000
- Pathways of As(III) detoxification in Saccharomyces cerevisiaeProceedings of the National Academy of Sciences, 1999
- Stage-Specific Activity of Pentavalent Antimony against Leishmania donovani Axenic AmastigotesAntimicrobial Agents and Chemotherapy, 1999
- Axenically Grown Amastigotes of Leishmania infantum Used as an In Vitro Model To Investigate the Pentavalent Antimony Mode of ActionAntimicrobial Agents and Chemotherapy, 1998
- Drug Resistance in Leishmaniasis: Its Implication in Systemic Chemotherapy of Cutaneous and Mucocutaneous DiseaseThe American Journal of Tropical Medicine and Hygiene, 1992